Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Prepaid Assets (2022 - 2025)

Axsome Therapeutics (AXSM) has disclosed Prepaid Assets for 4 consecutive years, with $13.7 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 13.97% to $13.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.7 million through Dec 2025, up 13.97% year-over-year, with the annual reading at $13.7 million for FY2025, 13.97% up from the prior year.
  • Prepaid Assets hit $13.7 million in Q4 2025 for Axsome Therapeutics, down from $19.8 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $19.8 million in Q3 2025 to a low of $2.1 million in Q1 2022.
  • Historically, Prepaid Assets has averaged $9.5 million across 4 years, with a median of $10.0 million in 2023.
  • Biggest five-year swings in Prepaid Assets: soared 191.8% in 2023 and later increased 13.97% in 2025.
  • Year by year, Prepaid Assets stood at $2.8 million in 2022, then skyrocketed by 191.8% to $8.1 million in 2023, then surged by 47.6% to $12.0 million in 2024, then increased by 13.97% to $13.7 million in 2025.
  • Business Quant data shows Prepaid Assets for AXSM at $13.7 million in Q4 2025, $19.8 million in Q3 2025, and $16.3 million in Q2 2025.